alexa
Reach Us +1 218 451 2974
Trigeminal Sensory Neuropathy in Mixed Connective Tissue Disease | OMICS International
ISSN: 2155-9562
Journal of Neurology & Neurophysiology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Trigeminal Sensory Neuropathy in Mixed Connective Tissue Disease

Sharika Rajan1, Rajesh Gupta1, Maria J Borja2, Naina Rastalksy3, Nagagopal Venna1 and Dinesh G Nair1*

1Department of Neurology, Massachusetts General Hospital, USA

2Department of Radiology, Massachusetts General Hospital, USA

3Department of Rheumatology, Massachusetts General Hospital, USA

*Corresponding Author:
Dinesh G Nair
Department of Neurology
Massachusetts General Hospital
15 Parkman St., Boston MA 02114-3117, USA
Tel: 617-726-3642
Fax: 617-726-2019
E-mail: [email protected]

Received date: October 03, 2016; Accepted date: October 04, 2016; Published date: October 07, 2016

Citation: Rajan S, Gupta R, Borja MJ, Rastalksy N, Venna N, et al. (2016) Trigeminal Sensory Neuropathy in Mixed Connective Tissue Disease. J Neurol Neurophysiol 7:i106. doi: 10.4172/2155-9562.1000i106

Copyright: © 2016 Rajan S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Neurology & Neurophysiology

Abstract

A 23 year old woman presented to the clinic with Raynaud's phenomenon and numbness and tingling in her right cheek, chin and the right side of her tongue. Examination showed altered facial sensation to touch and pinprick in the right V1-V3 distributions. When investigations revealed that her ANA was 1:5120 in a speckled pattern and anti- RNP was 243.79 U, a diagnosis of Mixed Connective Tissue Disease (MCTD) was made. MRI brain showed diffuse enhancement of the Trigeminal nerves bilaterally, right>left. Trigeminal sensory neuropathy is the most common CNS manifestation of MCTD and often the presenting symptom. Prognosis is variable, some features respond to glucocorticoids.

Keywords

Raynaud’s phenomenon; Trigeminal sensory neuropathy; Mixed connective tissue disease

Image Description

A 23 year old previously healthy woman presented to the clinic with initial symptoms suggestive of Raynaud’s phenomenon (Figure 1), followed a few weeks later by bitemporal headaches and numbness and tingling on her right cheek, chin and the right side of her tongue. She also complained of fatigue and itching all over her body. She had no rash, oral ulcers, joint pain, swelling or hearing loss.

neurology-neurophysiology-phenomenon

Figure 1: Raynaud’s phenomenon.

On examination, facial sensation was altered to touch and pinprick in the right V1-V3 distributions. When investigations revealed that her ANA was 1:5120 in a speckled pattern, anti- RNP was 243.79 U, with negative anti- Ro/La, Sm, dsDNA and SCL-70, a clinical diagnosis of Mixed Connective Tissue Disease (MCTD) was made. MRI brain is shown below (Figure 2). Compared to the pre-contrast T1-weighted image (Figure 2A), diffuse enhancement of the Trigeminal nerves (short white arrows) is seen bilaterally, right>left, in the post-contrast images (Figures 2B and 2C).

neurology-neurophysiology-MRI-brain

Figure 2: MRI brain.

Axial FIESTA sequence (Figure 2D) through the prepontine cistern and Meckel’s cave demonstrates asymmetric prominence of the right Trigeminal nerve (long white arrow).

Trigeminal sensory neuropathy is the most common CNS manifestation of MCTD and often, the presenting symptom [1,2]. Prognosis is variable, some features respond to glucocorticoids. No therapy is effective for trigeminal neuropathy [3]; anti-epileptics and antidepressants may provide some relief. For our patient, treatment with Corticosteroids and Rituximab resolved her headache completely, but she continued to have mild facial numbness.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 10612
  • [From(publication date):
    October-2016 - Jan 25, 2020]
  • Breakdown by view type
  • HTML page views : 10489
  • PDF downloads : 123
Top